|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions |
EXP |
4-cymene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with beta-pinene co-treated with gamma-terpinene co-treated with cuminol] results in increased activity of AHR protein; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] results in increased activity of AHR protein; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] results in increased activity of AHR protein |
CTD |
PMID:29191726 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions |
EXP |
4-cymene inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:29191726 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
|
G |
ACHE |
acetylcholinesterase (Yt blood group) |
decreases activity multiple interactions |
ISO |
carvacrol results in decreased activity of ACHE protein [propiconazole co-treated with carvacrol] results in decreased activity of ACHE protein |
CTD |
PMID:29852196 |
|
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in increased expression of ACTA2 protein] |
CTD |
PMID:34155936 |
|
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein]; carvacrol promotes the reaction [Simvastatin inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein]] |
CTD |
PMID:29071762 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AHR |
aryl hydrocarbon receptor |
increases activity multiple interactions |
EXP |
carvacrol results in increased activity of AHR protein [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] results in increased activity of AHR protein; carvacrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:29191726 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
ALB |
albumin |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in decreased expression of ALB protein] |
CTD |
PMID:34155936 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Ethanol results in increased expression of BAX protein] |
CTD |
PMID:37499997 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] |
CTD |
PMID:37499997 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CASP3 |
caspase 3 |
increases activity multiple interactions |
EXP ISO |
carvacrol results in increased activity of CASP3 protein carvacrol inhibits the reaction [Poloxamer results in increased expression of CASP3 protein]; carvacrol inhibits the reaction [propiconazole results in increased expression of CASP3 protein]; carvacrol inhibits the reaction [Simvastatin promotes the reaction [Poloxamer results in increased expression of CASP3 protein]]; carvacrol inhibits the reaction [Thioacetamide results in increased expression of CASP3 protein] |
CTD |
PMID:23146755 PMID:29071762 PMID:29852196 PMID:34155936 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
multiple interactions |
ISO EXP |
carvacrol inhibits the reaction [Ethanol results in decreased expression of CAT protein]; carvacrol inhibits the reaction [Poloxamer results in decreased activity of CAT protein]; carvacrol inhibits the reaction [propiconazole results in decreased activity of CAT protein]; carvacrol promotes the reaction [Simvastatin inhibits the reaction [Poloxamer results in decreased activity of CAT protein]] carvacrol inhibits the reaction [Diethylhexyl Phthalate results in increased activity of CAT protein] carvacrol inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein] |
CTD |
PMID:29019276 PMID:29071762 PMID:29852196 PMID:35521929 PMID:37499997 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CKM |
creatine kinase, M-type |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Poloxamer results in increased secretion of CKM protein]; carvacrol inhibits the reaction [Simvastatin results in increased secretion of CKM protein] |
CTD |
PMID:29071762 |
|
NCBI chr19:45,306,413...45,322,875
Ensembl chr19:45,306,413...45,322,875
|
|
G |
CRYZ |
crystallin zeta |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Benzo(a)pyrene results in decreased activity of CRYZ protein] |
CTD |
PMID:29019276 |
|
NCBI chr 1:74,705,486...74,733,050
Ensembl chr 1:74,705,482...74,733,408
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
ISO |
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in increased expression of CXCL1 protein]]; carvacrol inhibits the reaction [irinotecan results in increased expression of CXCL1 protein] |
CTD |
PMID:27838229 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
multiple interactions increases expression |
EXP |
carvacrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] carvacrol results in increased expression of CYP1A1 mRNA |
CTD |
PMID:29191726 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
EGFR |
epidermal growth factor receptor |
increases phosphorylation multiple interactions |
EXP |
carvacrol results in increased phosphorylation of EGFR protein KN 93 inhibits the reaction [carvacrol results in increased phosphorylation of EGFR protein]; TRPV3 protein affects the reaction [carvacrol results in increased phosphorylation of EGFR protein] |
CTD |
PMID:32535744 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in increased expression of ENPP2 protein] |
CTD |
PMID:34155936 |
|
NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
carvacrol affects the reaction [Streptozocin results in decreased expression of FSHB protein] |
CTD |
PMID:32153207 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
G |
FSHR |
follicle stimulating hormone receptor |
multiple interactions |
ISO |
carvacrol affects the reaction [Streptozocin results in decreased expression of FSHR mRNA]; carvacrol affects the reaction [Streptozocin results in decreased expression of FSHR protein] |
CTD |
PMID:32153207 |
|
NCBI chr 2:48,962,157...49,154,515
Ensembl chr 2:48,962,157...49,154,527
|
|
G |
GFAP |
glial fibrillary acidic protein |
multiple interactions |
ISO |
carvacrol inhibits the reaction [propiconazole results in increased expression of GFAP protein] |
CTD |
PMID:29852196 |
|
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in increased activity of GPT protein] |
CTD |
PMID:34155936 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Ethanol results in decreased expression of GPX1 protein] |
CTD |
PMID:37499997 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GPX4 |
glutathione peroxidase 4 |
affects binding |
EXP |
carvacrol binds to GPX4 protein |
CTD |
PMID:37499997 |
|
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
|
|
G |
HTR3A |
5-hydroxytryptamine receptor 3A |
increases activity |
EXP |
carvacrol results in increased activity of HTR3A protein |
CTD |
PMID:26456648 |
|
NCBI chr11:113,975,108...113,990,313
Ensembl chr11:113,975,075...113,990,313
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO EXP |
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in increased expression of IL1B protein]]; carvacrol inhibits the reaction [irinotecan results in increased expression of IL1B protein] carvacrol inhibits the reaction [Thioacetamide results in increased expression of IL1B protein] carvacrol inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA] |
CTD |
PMID:26801986 PMID:27838229 PMID:34155936 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
carvacrol affects the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:32153207 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
LEP |
leptin |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Poloxamer results in increased secretion of LEP protein] |
CTD |
PMID:29071762 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LHB |
luteinizing hormone subunit beta |
multiple interactions |
ISO |
carvacrol affects the reaction [Streptozocin results in decreased expression of LHB protein] |
CTD |
PMID:32153207 |
|
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
|
|
G |
LHCGR |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions |
ISO |
carvacrol affects the reaction [Streptozocin results in decreased expression of LHCGR mRNA]; carvacrol affects the reaction [Streptozocin results in decreased expression of LHCGR protein] |
CTD |
PMID:32153207 |
|
NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
|
|
G |
MB |
myoglobin |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Poloxamer results in increased secretion of MB protein] |
CTD |
PMID:29071762 |
|
NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
|
|
G |
MMP3 |
matrix metallopeptidase 3 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in increased expression of MMP3 protein] |
CTD |
PMID:34155936 |
|
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in increased expression of MMP9 protein] |
CTD |
PMID:34155936 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MPO |
myeloperoxidase |
multiple interactions |
ISO |
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in increased activity of MPO protein]]; carvacrol inhibits the reaction [irinotecan results in increased activity of MPO protein] |
CTD |
PMID:27838229 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in decreased expression of NFE2L2 protein] |
CTD |
PMID:34155936 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [irinotecan results in increased expression of NFKB1 protein] carvacrol inhibits the reaction [Ethanol results in increased expression of NFKB1 protein] |
CTD |
PMID:27838229 PMID:37499997 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein] carvacrol inhibits the reaction [Thioacetamide results in increased expression of NOS2 protein] |
CTD |
PMID:29019276 PMID:34155936 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOX1 |
NADPH oxidase 1 |
affects binding multiple interactions |
EXP ISO |
carvacrol binds to NOX1 protein carvacrol inhibits the reaction [Ethanol results in increased expression of NOX1 protein] |
CTD |
PMID:37499997 |
|
NCBI chr X:100,843,324...100,874,359
Ensembl chr X:100,843,324...100,874,359
|
|
G |
NOX4 |
NADPH oxidase 4 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Ethanol results in increased expression of NOX4 protein] |
CTD |
PMID:37499997 |
|
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
|
|
G |
NR5A1 |
nuclear receptor subfamily 5 group A member 1 |
multiple interactions |
ISO |
carvacrol affects the reaction [Streptozocin results in decreased expression of NR5A1 mRNA]; carvacrol affects the reaction [Streptozocin results in decreased expression of NR5A1 protein] |
CTD |
PMID:32153207 |
|
NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
|
|
G |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
multiple interactions increases phosphorylation |
EXP |
Erlotinib Hydrochloride inhibits the reaction [carvacrol results in increased phosphorylation of PIK3CA protein]; TRPV3 protein affects the reaction [carvacrol results in increased phosphorylation of PIK3CA protein] |
CTD |
PMID:32535744 |
|
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 protein]; carvacrol inhibits the reaction [Irinotecan results in increased expression of PTGS2 protein] carvacrol inhibits the reaction [propiconazole results in increased expression of PTGS2 protein] |
CTD |
PMID:27838229 PMID:29019276 PMID:29852196 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases phosphorylation |
EXP |
Erlotinib Hydrochloride inhibits the reaction [carvacrol results in increased phosphorylation of RELA protein]; TRPV3 protein affects the reaction [carvacrol results in increased phosphorylation of RELA protein] |
CTD |
PMID:32535744 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
TGFA |
transforming growth factor alpha |
multiple interactions increases secretion |
EXP |
KN 93 inhibits the reaction [carvacrol results in increased secretion of TGFA protein] |
CTD |
PMID:32535744 |
|
NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in increased expression of TGFB1 protein] |
CTD |
PMID:34155936 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO EXP |
2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [carvacrol inhibits the reaction [irinotecan results in increased expression of TNF protein]]; carvacrol inhibits the reaction [irinotecan results in increased expression of TNF protein] carvacrol inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA] carvacrol inhibits the reaction [Ethanol results in increased expression of TNF protein] |
CTD |
PMID:26801986 PMID:27838229 PMID:37499997 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TRPA1 |
transient receptor potential cation channel subfamily A member 1 |
increases activity |
ISO EXP |
carvacrol results in increased activity of TRPA1 protein |
CTD |
PMID:16617338 PMID:22935519 |
|
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
|
|
G |
TRPV3 |
transient receptor potential cation channel subfamily V member 3 |
increases activity affects response to substance multiple interactions increases response to substance |
EXP ISO |
carvacrol results in increased activity of TRPV3 protein TRPV3 protein affects the susceptibility to carvacrol TRPV3 protein affects the reaction [carvacrol results in increased phosphorylation of EGFR protein]; TRPV3 protein affects the reaction [carvacrol results in increased phosphorylation of PIK3CA protein]; TRPV3 protein affects the reaction [carvacrol results in increased phosphorylation of RELA protein] TRPV3 protein results in increased susceptibility to carvacrol [carvacrol results in increased activity of TRPV3 protein] which results in increased transport of Calcium [carvacrol binds to and results in increased activity of TRPV3 protein] which results in increased transport of Calcium; [carvacrol results in increased activity of TRPV3 protein] which results in increased transport of Calcium; carvacrol binds to and results in increased activity of TRPV3 protein; Ruthenium Red inhibits the reaction [[carvacrol binds to and results in increased activity of TRPV3 protein] which results in increased transport of Calcium] |
CTD |
PMID:16617338 PMID:20086034 PMID:29658714 PMID:32535744 |
|
NCBI chr17:3,510,502...3,557,812
Ensembl chr17:3,510,502...3,557,812
|
|
G |
TXN |
thioredoxin |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Thioacetamide results in increased expression of TXN protein] |
CTD |
PMID:34155936 |
|
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
|
|
G |
UGT2B15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of carvacrol |
CTD |
PMID:7835232 |
|
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
ISO |
carvacrol inhibits the reaction [Benzo(a)pyrene results in increased activity of XDH protein] |
CTD |
PMID:29019276 |
|
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
|
|
|
G |
AR |
androgen receptor |
multiple interactions |
EXP |
Tea Tree Oil inhibits the reaction [Testosterone results in increased activity of AR protein] |
CTD |
PMID:31393563 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
CTSD |
cathepsin D |
multiple interactions increases expression |
EXP |
Fulvestrant inhibits the reaction [Tea Tree Oil results in increased expression of CTSD mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
CYP4F8 |
cytochrome P450 family 4 subfamily F member 8 |
multiple interactions |
EXP |
Tea Tree Oil inhibits the reaction [Testosterone results in increased expression of CYP4F8 mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr19:15,615,218...15,630,639
Ensembl chr19:15,615,218...15,630,639
|
|
G |
ESR1 |
estrogen receptor 1 |
increases activity |
EXP |
Tea Tree Oil results in increased activity of ESR1 protein |
CTD |
PMID:31393563 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
GREB1 |
growth regulating estrogen receptor binding 1 |
multiple interactions increases expression |
EXP |
Fulvestrant inhibits the reaction [Tea Tree Oil results in increased expression of GREB1 mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
|
|
G |
PGR |
progesterone receptor |
increases expression multiple interactions |
EXP |
Tea Tree Oil results in increased expression of PGR mRNA Fulvestrant inhibits the reaction [Tea Tree Oil results in increased expression of PGR mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
SEC14L2 |
SEC14 like lipid binding 2 |
multiple interactions |
EXP |
Tea Tree Oil inhibits the reaction [Testosterone results in increased expression of SEC14L2 mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr22:30,397,018...30,425,303
Ensembl chr22:30,396,941...30,425,303
|
|
G |
UGT2B28 |
UDP glucuronosyltransferase family 2 member B28 |
multiple interactions |
EXP |
Tea Tree Oil inhibits the reaction [Testosterone results in increased expression of UGT2B28 mRNA] |
CTD |
PMID:31393563 |
|
NCBI chr 4:69,280,475...69,295,050
Ensembl chr 4:69,280,475...69,295,050
|
|
|
G |
ACP5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions increases activity |
EXP |
[4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] results in increased activity of AHR protein; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] results in increased activity of AHR protein; Thymol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] Thymol results in increased activity of AHR protein |
CTD |
PMID:29191726 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
affects localization |
EXP |
Thymol affects the localization of AIFM1 protein |
CTD |
PMID:21640085 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP ISO |
Thymol results in increased expression of BAX protein Thymol results in increased expression of BAX mRNA Thymol inhibits the reaction [imidacloprid results in increased expression of BAX mRNA] |
CTD |
PMID:21640085 PMID:34171690 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression multiple interactions |
EXP ISO |
Thymol results in decreased expression of BCL2 protein Thymol inhibits the reaction [imidacloprid results in decreased expression of BCL2 mRNA] |
CTD |
PMID:21640085 PMID:34171690 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] |
CTD |
PMID:26996544 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
CA2 |
carbonic anhydrase 2 |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493
|
|
G |
CASP3 |
caspase 3 |
increases activity multiple interactions |
EXP ISO |
Thymol results in increased activity of CASP3 protein Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 mRNA]; Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 protein] |
CTD |
PMID:21640085 PMID:34171690 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases activity multiple interactions |
EXP ISO |
Thymol results in increased activity of CASP8 protein Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA] |
CTD |
PMID:21640085 PMID:26996544 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases activity multiple interactions |
EXP ISO |
Thymol results in increased activity of CASP9 protein Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA] |
CTD |
PMID:21640085 PMID:26996544 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO EXP |
Thymol inhibits the reaction [imidacloprid results in decreased activity of CAT protein]; Thymol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein] Thymol inhibits the reaction [Diethylhexyl Phthalate results in increased activity of CAT protein] Thymol inhibits the reaction [Dietary Fats results in decreased activity of CAT protein] |
CTD |
PMID:26680107 PMID:26721194 PMID:34171690 PMID:35521929 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CTSK |
cathepsin K |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of CTSK protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein] |
CTD |
PMID:30048646 |
|
NCBI chr 1:150,796,208...150,808,260
Ensembl chr 1:150,794,880...150,809,577
|
|
G |
CYP11A1 |
cytochrome P450 family 11 subfamily A member 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP19A1 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression multiple interactions |
EXP |
Thymol results in increased expression of CYP1A1 mRNA Thymol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:29191726 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
DCSTAMP |
dendrocyte expressed seven transmembrane protein |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr 8:104,339,796...104,356,689
Ensembl chr 8:104,339,087...104,356,689
|
|
G |
DGAT2 |
diacylglycerol O-acyltransferase 2 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Ethanol results in increased expression of DGAT2 mRNA] |
CTD |
PMID:36535314 |
|
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions |
ISO |
Thymol inhibits the reaction [Isoproterenol results in increased expression of FAS mRNA] |
CTD |
PMID:26996544 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Thymol promotes the reaction [Lipopolysaccharides results in decreased expression of FOS protein] |
CTD |
PMID:30048646 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in increased expression of FSHB protein] |
CTD |
PMID:34171690 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
G |
GAB2 |
GRB2 associated binding protein 2 |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr11:78,215,293...78,417,820
Ensembl chr11:78,215,293...78,418,348
|
|
G |
GABRA1 |
gamma-aminobutyric acid type A receptor subunit alpha1 |
multiple interactions |
ISO |
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr 5:161,847,191...161,899,971
Ensembl chr 5:161,847,063...161,899,981
|
|
G |
GABRB2 |
gamma-aminobutyric acid type A receptor subunit beta2 |
multiple interactions |
ISO |
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr 5:161,288,436...161,548,404
Ensembl chr 5:161,288,429...161,549,044
|
|
G |
GABRG2 |
gamma-aminobutyric acid type A receptor subunit gamma2 |
multiple interactions |
ISO |
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
ISO |
Thymol inhibits the reaction [Dietary Fats results in decreased activity of GSR protein] |
CTD |
PMID:26680107 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HSD17B3 |
hydroxysteroid 17-beta dehydrogenase 3 |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr 9:96,235,306...96,302,176
Ensembl chr 9:96,235,306...96,302,176
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein]]; Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein] |
CTD |
PMID:36535314 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HTR3A |
5-hydroxytryptamine receptor 3A |
increases activity |
EXP |
Thymol results in increased activity of HTR3A protein |
CTD |
PMID:26456648 |
|
NCBI chr11:113,975,108...113,990,313
Ensembl chr11:113,975,075...113,990,313
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
[Thymol co-treated with Fluorouracil] results in increased expression of IL10 protein |
CTD |
PMID:34665902 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO EXP |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Thymol inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA] |
CTD |
PMID:26801986 PMID:30048646 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Fluorouracil results in increased expression of IL6 protein] |
CTD |
PMID:34665902 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
LHB |
luteinizing hormone subunit beta |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in increased expression of LHB protein] |
CTD |
PMID:34171690 |
|
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
|
|
G |
MAP1LC3A |
microtubule associated protein 1 light chain 3 alpha |
multiple interactions increases expression |
ISO |
Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein] Thymol results in increased expression of MAP1LC3A protein |
CTD |
PMID:36535314 |
|
NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345
|
|
G |
MITF |
melanocyte inducing transcription factor |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MITF mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr 3:69,739,464...69,968,332
Ensembl chr 3:69,739,456...69,968,336
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein] |
CTD |
PMID:30048646 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MYC mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
NFATC1 |
nuclear factor of activated T cells 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] |
CTD |
PMID:30048646 |
|
NCBI chr18:79,395,930...79,529,323
Ensembl chr18:79,395,856...79,529,325
|
|
G |
OGDH |
oxoglutarate dehydrogenase |
multiple interactions |
ISO |
Thymol inhibits the reaction [Isoproterenol results in decreased activity of OGDH protein] |
CTD |
PMID:26721194 |
|
NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,572...44,709,066
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of PCNA protein] |
CTD |
PMID:34171690 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein] |
CTD |
PMID:34665902 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Thymol inhibits the reaction [Fluorouracil results in increased expression of RELA protein] |
CTD |
PMID:34665902 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SQSTM1 |
sequestosome 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein] |
CTD |
PMID:36535314 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Dietary Fats results in increased expression of SREBF1 protein] |
CTD |
PMID:26680107 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
STAR |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of STAR mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Dietary Fats results in increased expression of TGFB1 protein] Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 protein] |
CTD |
PMID:26680107 PMID:34665902 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Thymol inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA] Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF protein] |
CTD |
PMID:26801986 PMID:30048646 PMID:34665902 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF11A |
TNF receptor superfamily member 11a |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF11A mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF11A protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr18:62,325,310...62,391,288
Ensembl chr18:62,325,287...62,391,288
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MITF mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MYC mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
TRPV3 |
transient receptor potential cation channel subfamily V member 3 |
increases activity |
ISO EXP |
Thymol results in increased activity of TRPV3 protein |
CTD |
PMID:16617338 |
|
NCBI chr17:3,510,502...3,557,812
Ensembl chr17:3,510,502...3,557,812
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
EXP |
UGT1A1 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
increases glucuronidation |
EXP |
UGT1A10 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A7 |
UDP glucuronosyltransferase family 1 member A7 |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
|
|
G |
UGT1A8 |
UDP glucuronosyltransferase family 1 member A8 |
increases glucuronidation |
EXP |
UGT1A8 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300
|
|
G |
UGT1A9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
EXP |
UGT1A9 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Thymol inhibits the reaction [Dietary Fats results in increased expression of VEGFA protein] |
CTD |
PMID:26680107 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
ACP5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions increases activity |
EXP |
[4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol co-treated with carvacrol] results in increased activity of AHR protein; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [4-cymene co-treated with gamma-terpinene co-treated with Thymol] results in increased activity of AHR protein; Thymol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] Thymol results in increased activity of AHR protein |
CTD |
PMID:29191726 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
affects localization |
EXP |
Thymol affects the localization of AIFM1 protein |
CTD |
PMID:21640085 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
EXP ISO |
Thymol results in increased expression of BAX protein Thymol results in increased expression of BAX mRNA Thymol inhibits the reaction [imidacloprid results in increased expression of BAX mRNA] |
CTD |
PMID:21640085 PMID:34171690 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
decreases expression multiple interactions |
EXP ISO |
Thymol results in decreased expression of BCL2 protein Thymol inhibits the reaction [imidacloprid results in decreased expression of BCL2 mRNA] |
CTD |
PMID:21640085 PMID:34171690 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] |
CTD |
PMID:26996544 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
CA2 |
carbonic anhydrase 2 |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493
|
|
G |
CASP3 |
caspase 3 |
increases activity multiple interactions |
EXP ISO |
Thymol results in increased activity of CASP3 protein Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 mRNA]; Thymol inhibits the reaction [imidacloprid results in increased expression of CASP3 protein] |
CTD |
PMID:21640085 PMID:34171690 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP8 |
caspase 8 |
increases activity multiple interactions |
EXP ISO |
Thymol results in increased activity of CASP8 protein Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA] |
CTD |
PMID:21640085 PMID:26996544 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases activity |
ISO EXP |
Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP9 mRNA] Thymol results in increased activity of CASP9 protein |
CTD |
PMID:21640085 PMID:26996544 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO EXP |
Thymol inhibits the reaction [Dietary Fats results in decreased activity of CAT protein] Thymol inhibits the reaction [Diethylhexyl Phthalate results in increased activity of CAT protein] Thymol inhibits the reaction [imidacloprid results in decreased activity of CAT protein]; Thymol inhibits the reaction [Isoproterenol results in decreased activity of CAT protein] |
CTD |
PMID:26680107 PMID:26721194 PMID:34171690 PMID:35521929 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CTSK |
cathepsin K |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of CTSK protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein] |
CTD |
PMID:30048646 |
|
NCBI chr 1:150,796,208...150,808,260
Ensembl chr 1:150,794,880...150,809,577
|
|
G |
CYP11A1 |
cytochrome P450 family 11 subfamily A member 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP11A1 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of CYP19A1 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression multiple interactions |
EXP |
Thymol results in increased expression of CYP1A1 mRNA Thymol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:29191726 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
DCSTAMP |
dendrocyte expressed seven transmembrane protein |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr 8:104,339,796...104,356,689
Ensembl chr 8:104,339,087...104,356,689
|
|
G |
DGAT2 |
diacylglycerol O-acyltransferase 2 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Ethanol results in increased expression of DGAT2 mRNA] |
CTD |
PMID:36535314 |
|
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions |
ISO |
Thymol inhibits the reaction [Isoproterenol results in increased expression of FAS mRNA] |
CTD |
PMID:26996544 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Thymol promotes the reaction [Lipopolysaccharides results in decreased expression of FOS protein] |
CTD |
PMID:30048646 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in increased expression of FSHB protein] |
CTD |
PMID:34171690 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
|
|
G |
GAB2 |
GRB2 associated binding protein 2 |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr11:78,215,293...78,417,820
Ensembl chr11:78,215,293...78,418,348
|
|
G |
GABRA1 |
gamma-aminobutyric acid type A receptor subunit alpha1 |
multiple interactions |
ISO |
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr 5:161,847,191...161,899,971
Ensembl chr 5:161,847,063...161,899,981
|
|
G |
GABRB2 |
gamma-aminobutyric acid type A receptor subunit beta2 |
multiple interactions |
ISO |
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr 5:161,288,436...161,548,404
Ensembl chr 5:161,288,429...161,549,044
|
|
G |
GABRG2 |
gamma-aminobutyric acid type A receptor subunit gamma2 |
multiple interactions |
ISO |
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] |
CTD |
PMID:11399263 |
|
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
ISO |
Thymol inhibits the reaction [Dietary Fats results in decreased activity of GSR protein] |
CTD |
PMID:26680107 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HSD17B3 |
hydroxysteroid 17-beta dehydrogenase 3 |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr 9:96,235,306...96,302,176
Ensembl chr 9:96,235,306...96,302,176
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
multiple interactions |
ISO |
Chloroquine inhibits the reaction [Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein]]; Thymol inhibits the reaction [Ethanol results in decreased expression of HSPA8 protein] |
CTD |
PMID:36535314 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HTR3A |
5-hydroxytryptamine receptor 3A |
increases activity |
EXP |
Thymol results in increased activity of HTR3A protein |
CTD |
PMID:26456648 |
|
NCBI chr11:113,975,108...113,990,313
Ensembl chr11:113,975,075...113,990,313
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
[Thymol co-treated with Fluorouracil] results in increased expression of IL10 protein |
CTD |
PMID:34665902 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO EXP |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Thymol inhibits the reaction [Acetaminophen results in increased expression of IL1B mRNA] |
CTD |
PMID:26801986 PMID:30048646 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Fluorouracil results in increased expression of IL6 protein] |
CTD |
PMID:34665902 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
LHB |
luteinizing hormone subunit beta |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in increased expression of LHB protein] |
CTD |
PMID:34171690 |
|
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
|
|
G |
MAP1LC3A |
microtubule associated protein 1 light chain 3 alpha |
multiple interactions increases expression |
ISO |
Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein] Thymol results in increased expression of MAP1LC3A protein |
CTD |
PMID:36535314 |
|
NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345
|
|
G |
MITF |
melanocyte inducing transcription factor |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MITF mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr 3:69,739,464...69,968,332
Ensembl chr 3:69,739,456...69,968,336
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of MMP9 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein] |
CTD |
PMID:30048646 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MYC mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
NFATC1 |
nuclear factor of activated T cells 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of NFATC1 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein] |
CTD |
PMID:30048646 |
|
NCBI chr18:79,395,930...79,529,323
Ensembl chr18:79,395,856...79,529,325
|
|
G |
OGDH |
oxoglutarate dehydrogenase |
multiple interactions |
ISO |
Thymol inhibits the reaction [Isoproterenol results in decreased activity of OGDH protein] |
CTD |
PMID:26721194 |
|
NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,572...44,709,066
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of PCNA protein] |
CTD |
PMID:34171690 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Fluorouracil results in increased expression of PTGS2 protein] |
CTD |
PMID:34665902 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Thymol inhibits the reaction [Fluorouracil results in increased expression of RELA protein] |
CTD |
PMID:34665902 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
SQSTM1 |
sequestosome 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein] |
CTD |
PMID:36535314 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Dietary Fats results in increased expression of SREBF1 protein] |
CTD |
PMID:26680107 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
STAR |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
Thymol inhibits the reaction [imidacloprid results in decreased expression of STAR mRNA] |
CTD |
PMID:34171690 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
ISO |
Thymol inhibits the reaction [Dietary Fats results in increased expression of TGFB1 protein] Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TGFB1 protein] |
CTD |
PMID:26680107 PMID:34665902 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Thymol inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA] Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF mRNA]; Thymol inhibits the reaction [Fluorouracil results in increased expression of TNF protein] |
CTD |
PMID:26801986 PMID:30048646 PMID:34665902 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF11A |
TNF receptor superfamily member 11a |
multiple interactions |
ISO |
Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF11A mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF11A protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr18:62,325,310...62,391,288
Ensembl chr18:62,325,287...62,391,288
|
|
G |
TNFSF11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MITF mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of MYC mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of TNFRSF11A mRNA] |
CTD |
PMID:30048646 |
|
NCBI chr13:42,562,736...42,608,013
Ensembl chr13:42,562,736...42,608,013
|
|
G |
TRPV3 |
transient receptor potential cation channel subfamily V member 3 |
increases activity |
EXP ISO |
Thymol results in increased activity of TRPV3 protein |
CTD |
PMID:16617338 |
|
NCBI chr17:3,510,502...3,557,812
Ensembl chr17:3,510,502...3,557,812
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
EXP |
UGT1A1 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
increases glucuronidation |
EXP |
UGT1A10 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A7 |
UDP glucuronosyltransferase family 1 member A7 |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,681,901...233,773,300
Ensembl chr 2:233,681,901...233,773,300
|
|
G |
UGT1A8 |
UDP glucuronosyltransferase family 1 member A8 |
increases glucuronidation |
EXP |
UGT1A8 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300
|
|
G |
UGT1A9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
EXP |
UGT1A9 protein results in increased glucuronidation of Thymol |
CTD |
PMID:14557274 |
|
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Thymol inhibits the reaction [Dietary Fats results in increased expression of VEGFA protein] |
CTD |
PMID:26680107 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|